Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Functional Sympatholysis and Exercise Intolerance in Chronic Kidney Disease
NCT02411773Phase 1Recruiting
- Sponsor
- Emory University
- Start
- Jun 2015
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of sodium bicarbonate in chronic kidney disease (CKD) (5 arms), sponsored by Emory University. Primary endpoints: Change in muscle oxygenation at Week 12, Change in muscle interstitial pH at Week 12 and 1 more. Started Jun 2015; status: recruiting.
02
Drugs
sodium bicarbonate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02411773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02411773.